ArticleCommunications medicine2025
Integrating large scale genetic and clinical information to predict cases of heart failure.
Article in Communications medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- AI-based multimodal integration of genomics and electronic health records.Nature reviews. Genetics · 2026Review
- A bibliometric analysis of artificial intelligence applications in heart failure.Journal of thoracic disease · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
Abstract
backgroundHeart failure (HF) is a major global cause of death. Early risk prediction and intervention could mitigate disease progression. We aimed to improve HF prediction by integrating genome-wide association studies (GWAS)- and electronic health records (EHR)-derived risk scores.
methodsWe previously performed a large HF GWAS within the Global Biobank Meta-analysis Initiative to create a polygenic risk score (PRS). Three Michigan Medicine (MM) cohorts were used to develop the clinical risk score (ClinRS): 1) Primary Care Provider cohort (MM-PCP; N = 61,849), 2) Heart Failure cohort (MM-HF; N = 53,272), and 3) Michigan Genomics Initiative cohort (MM-MGI; N = 60,215). To extract information from high-dimensional EHR data, we leveraged natural language processing to generate 350 latent phenotypes representing EHR codes and used coefficients from LASSO regression on these phenotypes in a training set as weights to calculate ClinRS in a validation set. Using logistic regression, model performances were compared between baseline model and models with risk scores added: 1) PRS, 2) ClinRS, and 3) ClinRS+PRS. We further compared the proposed models with Atherosclerosis Risk in Communities (ARIC) HF risk score.
resultsPRS and ClinRS each predict HF outcomes significantly better than the baseline model, up to eight years prior to HF diagnosis. Including both PRS and ClinRS further improves prediction performance up to ten years prior to diagnosis, two years earlier than either score alone. Additionally, ClinRS significantly outperforms the ARIC model one year prior.
conclusionsWe demonstrate the additive power of integrating GWAS- and EHR-derived risk scores to predict HF cases prior to diagnosis. This standardizable and scalable risk predictor may enable physicians to provide earlier interventions to improve patient outcomes.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.